Content

Highlights
Research Notes
Motivations: Donors & Alumni
More From This Issue

Past Issues

Download Magazine

Search

Subscribe

  • This field is for validation purposes and should be left unchanged.

Einstein Emerging Leaders Go Global

Einstein Emerging Leaders Go Global

Error: No layouts found

Members of Einstein Emerging Leaders (EEL), a group of New York City professionals committed to helping advance Einstein’s mission to improve human health, met recently with faculty and students from Einstein’s Global Health Center (GHC) at the Ohm Lounge in Manhattan.
They participated in round-table discussions led by GHC co-directors Kathryn Anastos, M.D., professor of medicine, and Louis M. Weiss, M.D., M.P.H., professor of pathology and of medicine; Johanna P. Daily, M.D., associate professor of medicine; H. Dean Hosgood, Ph.D., assistant professor of epidemiology & population health; fourth-year student Ken Shafer; and GHC program manager Jill Raufman, M.S., M.P.H.
Dr. Weiss gave an overview of the center and its work; Ms. Raufman spoke of her work with Kenyan youth; Dr. Anastos talked about programs she started for Rwandan women with HIV/AIDS; Dr. Hosgood described his studies of non-smoking Nigerian women who may be at risk for lung cancer; Dr. Daily explained her malaria research in Malawi; and Mr. Shafer shared his experiences as a recently returned global health fellow in Uganda.
Adam Friedman, M.D. ’06, assistant professor of medicine (dermatology) and of physiology & biophysics, and Dr. Karthik Krishnamurthy, assistant professor of medicine (dermatology), who both serve on the EEL board and co-chair its education committee, organized the event with Ms. Raufman.

The Issue at a Glance

Highlights
Research Notes
Motivations: Donors & Alumni
More From This Issue

More From Einstein

Class of 2024 Celebrates Match Day
Einstein Community Enjoys Pi Day
Graduate Students Win Marmur Award
Empowering Einstein Women in Science
Einstein Secures $192M in NIH Grants
Training the Next Cancer Researchers
Bringing a Novel Drug to Market
A Promise to Rwandan Genocide Survivors